Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,341	1,985	1,376	719	486	511
Market Cap Growth	54.13%	44.25%	91.51%	47.79%	-4.80%	-7.70%
Enterprise Value	3,284	2,018	1,378	535	299	380
Last Close Price	65.00	41.35	29.52	19.50	15.95	17.46
PS Ratio	6.80	5.89	7.38	9.32	25.41	-
PB Ratio	11.42	8.80	5.53	5.06	4.04	2.97
P/TBV Ratio	55.54	-	-	8.65	4.79	2.97
P/FCF Ratio	75.38	212.71	-	-	-	-
P/OCF Ratio	74.75	192.25	-	-	-	-
EV/Sales Ratio	6.96	5.99	7.39	6.95	15.62	-
EV/FCF Ratio	74.10	216.27	-	-	-	-
Debt / Equity Ratio	1.09	1.41	1.24	0.02	0.02	0.02
Debt / FCF Ratio	7.19	34.05	-	-	-	-
Asset Turnover	0.65	0.51	0.37	0.24	0.07	-
Inventory Turnover	4.16	3.65	3.38	3.50	-	-
Quick Ratio	3.01	2.83	4.07	2.72	3.76	12.56
Current Ratio	3.31	3.10	4.45	2.94	3.91	12.80
Return on Equity (ROE)	-15.81%	-37.08%	-83.65%	-103.46%	-57.47%	-68.29%
Return on Assets (ROA)	-3.60%	-8.31%	-13.65%	-25.33%	-40.48%	-33.64%
Return on Capital (ROIC)	-4.50%	-9.95%	-19.46%	-61.42%	-72.69%	-42.14%
Return on Capital Employed (ROCE)	-6.70%	-16.10%	-19.50%	-45.50%	-68.80%	-46.90%
Earnings Yield	-1.24%	-4.43%	-11.88%	-18.88%	-17.27%	-20.22%
FCF Yield	1.33%	0.47%	-5.16%	-16.76%	-27.31%	-17.48%
Buyback Yield / Dilution	-4.69%	-16.23%	-20.31%	-12.07%	-20.08%	-119.84%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q